After years of strong gains, Singapore’s three major banks have suddenly been hit by a sharp two-day sell-off. The obvious question for investors is: has the correction finally made DBS, OCBC and UOB attractive again?

The answer is more complicated than simply saying that the stocks are “cheaper”.

As of October 8, 2026, DBS closed at S$73.85, OCBC at S$29.00 and UOB at S$40.25.

That followed an already painful session on October 7, when OCBC plunged 5.9%, DBS fell 1.4% and UOB declined 2.9%.

Over the two sessions, the declines have become substantial.

OCBC has fallen about 10.0%, DBS about 6.0% and UOB about 7.9%, based on their October 6 closing prices.

The immediate catalyst was Citi’s downgrade of OCBC.

But the broader sell-off is about something more important:

Singapore bank valuations had become elevated after an extraordinary rally, while investors were becoming less confident that earnings could continue surprising on the upside.

That creates the central question for investors today:

After the sell-off, are DBS, OCBC and UOB finally cheap — or are they merely less expensive than they were two days ago?

The three banks are still fundamentally strong

Before discussing valuation, it is important to establish what has not changed.

There has been no sudden deterioration in the financial condition of Singapore’s three largest banks.

The latest reported results remain robust.

DBS

DBS reported S$3.08 billion of net profit in 2Q26, up 9% year-on-year.

For 1H26, net profit reached a record S$6.01 billion, up 5%.

Return on equity was 17.5%, while the bank’s non-performing loan ratio remained at just 1.0%.

However, there was an important warning sign beneath the headline numbers: second-quarter net interest income fell 2% year-on-year, while net interest margin declined 18 basis points to 1.87% as lower interest rates pressured margins.

So DBS remains highly profitable.

But its earnings mix is changing.

The bank is increasingly relying on fee income, wealth management and treasury-related businesses to offset pressure on traditional net interest income.

OCBC

OCBC’s 1H26 results were even stronger on the headline numbers.

Net profit increased 13% to a record S$4.19 billion.

Total income increased 11% to S$8.00 billion.

But the composition of that income is particularly important for the current share-price debate.

Net interest income fell 3%, while non-interest income surged 36% to a record S$3.51 billion.

Wealth-management income rose 27% to S$3.29 billion, while net trading income increased 46% to S$1.13 billion.

OCBC’s annualised ROE was 13.7% and its NPL ratio remained a healthy 0.9%.

These are excellent numbers.

But they also explain why the market has become nervous.

When such a large proportion of earnings growth comes from exceptionally strong trading, wealth-management and insurance income, investors inevitably ask:

Can that pace continue?

That is precisely the concern behind Citi’s downgrade.

UOB

UOB reported S$1.48 billion of 2Q26 net profit, up 10% year-on-year.

For the first half, net profit increased 3%.

Loan growth was 5%, while net interest income declined 2% because of margin pressure from the lower-rate environment.

UOB also declared an interim dividend of 88 cents per share, up from 85 cents previously.

Its balance sheet remains solid.

At end-June, UOB had a CET1 capital ratio of 15.4%, while its NPL ratio was 1.6%.

Again, this is not a story about a bank in financial trouble.

It is a story about how much investors should pay for these earnings.

So what are investors actually paying today?

This is where the recent correction becomes interesting.

At the October 8 closing prices, third-party market data showed:

The valuation data are based on market data available on October 8; dividend yields are based on trailing dividends and therefore should not be confused with forward dividend yields.

Immediately, something stands out.

UOB looks cheapest.

On a price-to-book basis, UOB trades at roughly 1.3 times book value, substantially below OCBC and DBS.

Its trailing P/E is also lower.

This is one reason several analysts have highlighted UOB’s relative valuation.

OCBC sits in the middle.

OCBC trades at roughly 2.1 times book value and around 17 times trailing earnings.

That is substantially higher than its historical valuation levels.

Market data show OCBC’s P/B ratio at around 1.4 times at the end of 2025 versus about 2.1 times today.

So although OCBC has fallen sharply, it has not suddenly returned to its old valuation regime.

DBS remains the valuation outlier.

DBS trades at more than 3 times book value on current market data.

That is a very substantial premium.

But the market is not paying that premium for no reason.

DBS has generated exceptional profitability, with 1H26 ROE of 17.5%, materially higher than OCBC’s 13.7% and UOB’s 11.8% reported 2Q26 annualised ROE.

This creates an important investment debate:

Should DBS trade at a substantial premium because its returns are substantially better?

There is a reasonable argument that it should.

The harder question is:

How large should that premium be?

The most interesting number may be OCBC’s re-rating

OCBC is particularly interesting because its valuation has changed dramatically.

At the end of 2025, OCBC had a P/E ratio of about 12.1 times and P/B of about 1.4 times, according to S&P Global Market Intelligence data.

By October 8, those figures had risen to roughly 17.4 times and 2.1 times, respectively.

So despite the two-day crash, investors should remember something important:

OCBC’s share price has not merely risen because earnings increased. The market has also dramatically expanded the multiple it is willing to pay for those earnings.

The bank’s market capitalisation has risen from about S$88.7 billion at the end of 2025 to around S$130 billion now.

That is a roughly 47% increase in market value.

This helps explain why a downgrade can have such a powerful impact.

When expectations are high, investors don’t need to believe that earnings will fall.

They merely need to believe that earnings will not grow as quickly as previously expected.

But valuation alone does not tell the whole story

There is an important trap here.

A bank trading at a lower P/B ratio isn’t automatically cheaper.

The appropriate valuation depends partly on the bank’s ability to generate returns on equity.

This is why DBS deserves a premium to UOB.

DBS generated a 1H26 ROE of 17.5%.

OCBC reported annualised 1H26 ROE of 13.7%.

UOB reported annualised 2Q26 ROE of 11.8%.

There is therefore a clear relationship:

Higher ROE → potentially higher justified P/B multiple.

That makes a simplistic comparison of P/B ratios misleading.

UOB being at 1.3 times book does not automatically mean it is a bargain.

Likewise, DBS at more than 3 times book does not automatically mean it is expensive.

The real question is whether the difference in profitability justifies the difference in valuation.

Dividends provide another layer of support

For income investors, the recent correction has made the three banks somewhat more attractive.

Based on trailing dividends, current yields are roughly:

• DBS: 4.3%
• OCBC: 3.6%
• UOB: 4.0%

These are not spectacular yields by historical Singapore-bank standards.

But they become more interesting when combined with the banks’ capital strength and potential for future distributions.

DBS in particular has been returning substantial amounts of capital to shareholders.

OCBC has also committed to completing its previously announced S$2.5 billion capital-return programme by FY2026, while its 1H26 interim dividend was raised 15% to 47 cents per share.

UOB raised its interim dividend to 88 cents from 85 cents.

This provides an important valuation floor.

But it is not an absolute floor.

Dividends cannot completely protect a stock from multiple compression.

The big problem: earnings expectations

This is where the current correction becomes more important than the headline share-price declines.

Analysts are not predicting a collapse in Singapore-bank earnings.

Instead, they are questioning the pace and quality of future growth.

Jefferies expects loan growth and wealth management to remain supportive, while NIM pressure becomes less severe.

However, it expects some normalisation in trading and other non-interest income after the exceptionally strong second quarter.

That is particularly relevant to OCBC.

The bank’s 1H26 non-interest income grew 36%.

Its trading income grew 46%.

Its wealth-management income increased 27%.

Those numbers are difficult to repeat indefinitely.

And when a stock’s valuation has expanded substantially in anticipation of continued strong growth, even a return to normal growth can cause a substantial share-price adjustment.

What about interest rates?

This is another reason the valuation debate is complicated.

The market has recently become more optimistic about Singapore rates.

RHB expects rising benchmark rates to support bank operating income, while Jefferies believes NIM pressure is becoming less severe.

That could be positive for the banks.

But there is a paradox.

Higher rates can help bank earnings while simultaneously hurting equity valuations.

Why?

Because higher bond yields increase the return available from relatively lower-risk assets.

If investors can obtain substantially higher yields from bonds, they may demand a larger risk premium before paying high multiples for bank shares.

This is particularly relevant to DBS, OCBC and UOB after their enormous re-rating.

Which bank looks most interesting after the sell-off?

This is where investors may reach different conclusions.

DBS: best quality, highest valuation

The bull case for DBS is straightforward.

It has:

• the highest ROE of the three;
• a very strong capital position;
• substantial wealth-management scale;
• a powerful regional franchise;
• strong dividend capacity; and
• a demonstrated ability to generate high returns.

But investors are paying for that quality.

At more than 3 times book value and roughly 20 times trailing earnings, DBS does not look conventionally cheap.

Its investment case therefore depends on maintaining superior profitability.

OCBC: strongest earnings momentum, but expectations were high

OCBC may be the most interesting turnaround-in-valuation story.

The stock has fallen sharply.

Its underlying business remains strong.

Its wealth franchise is growing rapidly.

Its balance sheet is robust.

But its valuation had expanded dramatically.

The crucial question is whether the current price adequately reflects the possibility of slower earnings growth.

Citi’s S$27.50 target is clearly bearish, but other analysts remain much more positive.

RHB, for example, maintained OCBC as its top Singapore-bank pick and had a S$33.70 target price immediately before the latest sell-off.

That enormous difference in views tells investors something important:

OCBC is now a valuation debate, not a consensus trade.

UOB: perhaps the most obvious value candidate

UOB’s attraction is simpler.

Its P/B and P/E ratios are considerably lower than those of DBS and OCBC.

It also offers roughly a 4% trailing dividend yield.

Analysts have highlighted the bank’s relative valuation as one of its attractions.

The trade-off is that UOB currently generates a lower ROE than DBS.

Its investment case therefore depends on whether profitability can improve as margins stabilise and ASEAN growth continues.

So, are Singapore bank stocks finally cheap?

Not across the board.

That is probably the most important conclusion.

The sell-off has certainly made the banks cheaper.

But cheaper does not necessarily mean cheap.

DBS

High quality, high ROE, strong dividend capacity — but still a premium valuation.

OCBC

The biggest recent valuation reset, strong earnings momentum and attractive franchise — but expectations remain high.

UOB

The lowest valuation of the three and a solid dividend yield — but also lower profitability.

That creates three different investment propositions.

And that is actually more useful for investors than simply declaring one of them the winner.

The number I would watch next

For me, the most important number over the next few quarters is not the share price.

It is ROE relative to valuation.

If DBS can continue generating ROE around the high teens, its premium valuation becomes easier to defend.

If OCBC can maintain ROE around the mid-teens while continuing to grow wealth-management earnings, its recent valuation may prove justified.

If UOB can lift ROE from the low teens while maintaining its lower valuation, the stock could offer the most compelling re-rating potential.

But if ROEs start falling while valuations remain elevated, the banks could have further to go.

That is the real risk.

The bigger question: has the correction finished?

Probably too early to say.

The three banks have only just begun correcting after a very powerful rally.

And the next major catalyst will be their third-quarter earnings.

OCBC’s third-quarter results are currently scheduled for November 6, while DBS is scheduled for November 5.

Those results could determine whether the market’s concerns are justified.

If earnings remain resilient, NIMs stabilise and wealth-management income continues to grow, investors may conclude that the recent sell-off was excessive.

But if trading and fee income normalise sharply while margins remain under pressure, the market could decide that the previous valuations were simply too high.

That is why investors should not rush to declare a bottom.

The verdict

The two-day sell-off has changed the risk-reward equation for Singapore’s banks.

But it has not transformed all three into obvious bargains.

DBS remains the highest-quality franchise — but investors are still paying a substantial premium for it.

OCBC has experienced the most dramatic valuation re-rating and now offers a more interesting entry point, but the market still needs to see whether its exceptional 1H26 earnings momentum can continue.

UOB looks the cheapest on conventional valuation measures and offers an attractive dividend yield, but its lower ROE means the discount is not necessarily unjustified.

The bigger opportunity may therefore not be asking:

“Which bank has fallen the most?”

It is asking:

“Which bank has the best combination of valuation, sustainable ROE, earnings growth and shareholder returns?”

That is the question investors should be asking as Singapore’s bank correction develops.

And there is one more reason not to rush.

The three banks make up an enormous portion of the STI.

If this is simply a healthy valuation reset, the correction could eventually create an attractive buying opportunity.

But if the sell-off is the beginning of a broader de-rating of Singapore equities, the banks may have further to fall before the real opportunity emerges.

For investors, the next few weeks could therefore be much more important than the last two days.

The Singapore bank rally may not be over. But the era in which investors could simply buy DBS, OCBC or UOB at almost any price may be.